FDA upgrades recall for tens of thousands of bottles of commonly prescribed medication
CINCINNATI (WKRC) – The FDA upgraded a recall for a commonly prescribed medication that may pose a health…
BCBS Massachusetts offers buyouts to more than 750 employees – Modern Healthcare
BCBS Massachusetts offers buyouts to more than 750 employees Modern HealthcareBlue Cross offers buyouts to hundreds of employees amid…
What It Means for Access
Shortly before the federal government shut down last week, officials at the Food and Drug Administration quietly approved…
FDA reverses NMN decision
Agency responds to petition by Natural Products Association and Alliance for Natural Health, allowing NMN as a dietary…
‘Don’t Take Tylenol’ Message Is Sharply Rebuked Outside U.S.
Tylenol brand pain reliever (acetaminophen) is under fire by the Trump administration for possible links to autism. Photographer:…
Rankin County teen wins battle for treatment with FDA drug approval
RANKIN CO., Miss. (WLBT) – The U.S. Food and Drug Administration’s denial of a life-changing medication pushed a…
FDA rejects Rexulti-Zoloft combo for PTSD
The FDA reÂjectÂed OtÂsuÂka and LundÂbeck’s RexÂulÂti and Zoloft comÂbiÂnaÂtion treatÂment for PTSD, months afÂter raisÂing conÂcerns about…
San Antonio clinics use magnetic fields to treat major depression
San Antonio residents who suffer from depression have historically had access to two clinical treatment options: psychotherapy and…
FDA cracks down on prescription drug ads but lacks staff
WASHINGTON – In an unprecedented move, federal regulators published about 100 warning letters sent to pharmaceutical companies and health…
Apple Watch Series 11 receives FDA clearance for hypertension alerts
Apple’s Awe Dropping event started with dramatic health testimonials from Apple Watch users, then revealed a key new…
Correlation Between Diabetes and Risk of Uveitis Confirmed in Recent Study
Darren Jindal, PhD | Image Credit: Case Western Reserve University School of Medicine Patients with type 1 or…
Saol Therapeutics hit with CRL for rare genetic disease
The U.S. FDA issued a complete response letter (CRL) for the NDA to privately held Saol Therapeutics Inc.’s…